Opportunities for Input/Comment to FDA
Advisory Committee Meetings
Guidance documents represent the Agency's current thinking on a particular subject.
Diabetes-related Advisory Committees/Panels
Advisory committees provide FDA with independent advice from outside experts on issues related to drugs, biological products, medical devices, and food.
Endocrinologic and Metabolic Drugs Advisory Committee Gastroenterology and Urology Devices Panel General Hospital and Personal Use Devices Panel Clinical Chemistry and Clinical Toxicology Devices Panel Circulatory System Devices Panel Vaccines and Related Biological Products Advisory Committee Public Workshop - Accessible Medical Device Labeling in a Standard Content and Format, April 29-30, 2013 June 5-6, 2013: Joint Meeting of the Endocrinilogic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement Center for Devices and Radiological Health: Health of Women Program Public Workshop
Advisory Committee Meetings and Public Meetings
Charging for Investigational Drugs Under an IND — Qs & As(PDF - 57KB) Expanded Access to Investigational Drugs for Treatment Use — Qs & As(PDF - 75KB) Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives Part 15 Public Meeting; Request for Comments
- 2012 Materials of the Gastroenterology-Urology Devices Panel
2012 Meeting Materials, Endocrinologic and Metabolic Drugs Advisory Committee 2012 Meeting Materials, Vaccines and Related Biological Products Advisory Committee 2011 Meeting Materials of the Circulatory System Devices Panel 2010 Meeting Materials of the General Hospital and Personal Use Devices Panel 2009 Meeting Materials of the Clinical Chemistry and Clinical Toxicology Devices Panel